113 related articles for article (PubMed ID: 30728908)
1. Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta.
Schulz D; Stancev I; Sorrentino A; Menevse AN; Beckhove P; Brockhoff G; Hautmann MG; Reichert TE; Bauer RJ; Ettl T
Oncotarget; 2019 Jan; 10(5):573-583. PubMed ID: 30728908
[TBL] [Abstract][Full Text] [Related]
2. Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma.
Schulz D; Streller M; Piendl G; Brockhoff G; Reichert TE; Menevse AN; Beckhove P; Hautmann MG; Bauer RJ; Ettl T
Carcinogenesis; 2020 Jul; 41(7):984-992. PubMed ID: 31637423
[TBL] [Abstract][Full Text] [Related]
3. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
[No Abstract] [Full Text] [Related]
4. PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma.
Müller T; Braun M; Dietrich D; Aktekin S; Höft S; Kristiansen G; Göke F; Schröck A; Brägelmann J; Held SAE; Bootz F; Brossart P
Oncotarget; 2017 Aug; 8(32):52889-52900. PubMed ID: 28881780
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.
Oweida A; Lennon S; Calame D; Korpela S; Bhatia S; Sharma J; Graham C; Binder D; Serkova N; Raben D; Heasley L; Clambey E; Nemenoff R; Karam SD
Oncoimmunology; 2017; 6(10):e1356153. PubMed ID: 29123967
[TBL] [Abstract][Full Text] [Related]
6. Current studies of immunotherapy in head and neck cancer.
Dogan V; Rieckmann T; Münscher A; Busch CJ
Clin Otolaryngol; 2018 Feb; 43(1):13-21. PubMed ID: 28464441
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma.
Schulz D; Wetzel M; Eichberger J; Piendl G; Brockhoff G; Wege AK; Reichert TE; Ettl T; Bauer RJ
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884892
[TBL] [Abstract][Full Text] [Related]
8. PD-1 and PD-L1 Expression Predicts Radiosensitivity and Clinical Outcomes in Head and Neck Cancer and is Associated with HPV Infection.
Lyu X; Zhang M; Li G; Jiang Y; Qiao Q
J Cancer; 2019; 10(4):937-948. PubMed ID: 30854100
[No Abstract] [Full Text] [Related]
9. Expression of tumoral GSK3-β, PD-L1, and CD8 cell density in urothelial carcinomas, association with tumor grade and overall survival.
Almeida Rodrigues AK; Silva PG; Nogueira C; Ferreira SS; Cordeiro J; Carneiro B; Tavora F
Am J Clin Exp Immunol; 2023; 12(5):87-97. PubMed ID: 38022872
[TBL] [Abstract][Full Text] [Related]
10. Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma.
Ock CY; Kim S; Keam B; Kim S; Ahn YO; Chung EJ; Kim JH; Kim TM; Kwon SK; Jeon YK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
Oncotarget; 2017 Nov; 8(58):97920-97927. PubMed ID: 29228662
[TBL] [Abstract][Full Text] [Related]
11. DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU).
Lailler C; Lamuraglia M; Racine F; Louandre C; Godin C; Chauffert B; Galmiche A; Saidak Z
Transl Oncol; 2021 Aug; 14(8):101110. PubMed ID: 33951601
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays.
Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238
[TBL] [Abstract][Full Text] [Related]
13. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer.
Ren J; Liu T; Han Y; Wang Q; Chen Y; Li G; Jiang L
Diagn Pathol; 2018 May; 13(1):33. PubMed ID: 29793508
[TBL] [Abstract][Full Text] [Related]
14. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Jang BS; Kim IA
Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
[TBL] [Abstract][Full Text] [Related]
15. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
[TBL] [Abstract][Full Text] [Related]
16. GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC.
Lin C; Cao W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Liu Z; Peng C; Wang L; Wang X; Ji T
Oncoimmunology; 2017; 6(11):e1353860. PubMed ID: 29147602
[TBL] [Abstract][Full Text] [Related]
17. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract][Full Text] [Related]
18. Significance of PD-L1 expression in pulmonary metastases from head and neck squamous cell carcinoma.
Okada S; Itoh K; Ishihara S; Shimada J; Kato D; Tsunezuka H; Miyata N; Hirano S; Teramukai S; Inoue M
Surg Oncol; 2018 Jun; 27(2):259-265. PubMed ID: 29937180
[TBL] [Abstract][Full Text] [Related]
19. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
[TBL] [Abstract][Full Text] [Related]
20. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
Wu Q; Zhao Y; Sun Y; Yan X; Wang P
Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
